Invited by Invest In Denmark (IDK), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and Adamed Corporation, the SINO-PhIRDA delegation led by Executive President Song Ruilin visited Denmark, Switzerland and Poland from June 25 to July 5, 2012.

 The delegation had productive meetings with representatives from local governments and pharmaceutical associations, visited world-leading companies, including: Roche HQ, Novartis HQ, CMC Biologics, BGI Europe and Adamed. It is believed that the collaborations in pharmaceutical industry between China and Europe will be further promoted through this visit.

 Mr. Lou Jing (CEO of Shenyang Sunshine Pharmaceutical Co., Ltd.), Mr. Jiang Bin (Director of Investment Service Bureau of Chengdu High-Tech) and Mr. Wang Xin (Director of International Cooperation at SINO-PhIRDA) also attended the event.

 <1> Mr. Song Ruilin, Executive President of SINO-PhIRDA met with Mr. Eduardo Pisani, Director General of IFPMA in Geneva in June 2012.

 SINO-PhIRDA delegates met with IFPMA representatives in Geneva in June 2012.

<2> SINO-PhIRDA delegation visited Roche HQ located in Basel in July 2012.

<3> SINO-PhIRDA delegation visited Novartis HQ located in Basel in July 2012.

    <4> Invited by Invest In Denmark, SINO-PhIRDA delegation visited CMC Biologics located in Copenhagen in June 2012.

<5> Invited by Invest In Denmark, SINO-PhIRDA delegation visited BGI Europe located in Copenhagen in June 2012.

<6> SINO-PhIRDA delegation visited Adamed Group located in Warsaw in July 2012.